Pulmonx (LUNG) Other financing activities (2019 - 2025)

Pulmonx (LUNG) has 7 years of Other financing activities data on file, last reported at $5000.0 in Q3 2025.

• On a quarterly basis, Other financing activities fell 82.14% year-over-year to $5000.0 in Q3 2025; TTM through Sep 2025 was $253000.0, a 47.09% increase from a year earlier, with the FY2024 full-year figure at $218000.0, down 29.68% from the prior year.
• Other financing activities for Q3 2025 stood at $5000.0, down from $28000.0 in the prior quarter.
• Over the last five years, Other financing activities for LUNG reached as high as $1.3 million in Q2 2021 and fell as low as $5000.0 in Q3 2025.
• Historically, Other financing activities has averaged $167684.2 across 5 years, with a median of $72000.0 in 2022.
• Across the five-year window, Other financing activities slumped 96.95% in 2021 and surged 200.0% in 2022, its largest moves.
• Year by year, Other financing activities stood at $150000.0 in 2021, then gained by 26.67% to $190000.0 in 2022, then slumped by 66.32% to $64000.0 in 2023, then soared by 71.88% to $110000.0 in 2024, then plunged by 95.45% to $5000.0 in 2025.
• Per Business Quant data, the three most recent Other financing activities figures were $5000.0 in Q3 2025, $28000.0 in Q2 2025, and $110000.0 in Q1 2025.